<p>理想情况下，您的整体投资组合应该超过市场平均水平。但几乎每位投资者都肯定会拥有表现优异和表现不佳的股票。在这一点上，一些股东可能在质疑他们对 <strong>Tate &amp; Lyle plc</strong> (LON:TATE) 的投资，因为过去五年股价下跌了 53%。而一些最近的买家可能也感到担忧，因为该股票在过去一年中下跌了 48%。股东们最近的表现更为糟糕，股价在过去 90 天内下跌了 29%。</p>
<p>由于股东们在长期内处于亏损状态，让我们看看这段时间的基本面，看看它们是否与回报一致。</p>
<p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前布局。</p>
<p>虽然市场是一个强大的定价机制，但股价反映的是投资者情绪，而不仅仅是基础业务表现。评估公司情绪变化的一个有缺陷但合理的方法是将每股收益（EPS）与股价进行比较。</p>
<p>在股价下跌的五年中，Tate &amp; Lyle 的每股收益（EPS）每年下降了 28%。每股收益的下降幅度超过了 14% 的年复合股价下跌幅度。相对温和的股价反应可能是因为市场预计业务会有所好转。以 47.44 的市盈率来看，可以说市场对该业务的未来持乐观态度。</p>
<p>下图显示了每股收益随时间的变化（如果您点击图像，可以看到更详细的信息）。</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/377904-earnings-per-share-growth-1-dark-2/1765614527926?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/377904-earnings-per-share-growth-1-dark-2/1765614527926"/></p>
<p>LSE:TATE 每股收益增长 2025 年 12 月 13 日</p>
<p>值得注意的是，我们在上个季度看到显著的内部人士买入，这被我们视为积极信号。另一方面，我们认为收入和收益趋势是衡量业务更有意义的指标。通过查看 Tate &amp; Lyle 的收益、收入和现金流的互动图表，可以更深入地了解收益情况。</p>
<h2>股息情况如何？</h2>
<p>在考虑投资回报时，重要的是要考虑 <em>总股东回报</em> (TSR) 和 <em>股价回报</em> 之间的差异。TSR 是一种回报计算，考虑了现金股息的价值（假设收到的任何股息都被再投资）以及任何折扣资本筹集和分拆的计算价值。可以说，TSR 提供了股票产生的回报的更全面的图景。在 Tate &amp; Lyle 的情况下，过去 5 年的 TSR 为-35%。这超过了我们之前提到的股价回报。因此，公司支付的股息提升了 <em>总</em> 股东回报。</p>
<h2>不同的视角</h2>
<p>Tate &amp; Lyle 的股东今年下跌了 46%（即使包括股息），但市场本身上涨了 20%。即使是优质股票的股价有时也会下跌，但我们希望在对业务产生浓厚兴趣之前，看到基本指标的改善。不幸的是，去年的表现可能表明存在未解决的挑战，因为其表现比过去五年年化损失 6% 还要糟糕。我们意识到巴伦·罗斯柴尔德曾说过，投资者应该在 “街头有血时” 买入，但我们提醒投资者首先要确保他们购买的是高质量的企业。长期跟踪股价表现总是很有趣。但要更好地理解 Tate &amp; Lyle，我们需要考虑许多其他因素。即便如此，请注意，Tate &amp; Lyle 在我们的投资分析中显示出 <strong>4 个警告信号</strong>，其中 2 个令人担忧……</p>
<p>Tate &amp; Lyle 并不是唯一一个内部人士在买入的股票。所以请查看这份 <strong>免费</strong> 的吸引人估值的小型公司名单，内部人士正在买入。</p>
<p><em>请注意，本文中引用的市场回报反映了目前在英国交易所交易的股票的市场加权平均回报。</em></p>
<p>移动基础设施用于国防和灾害</p>
<p>下一波机器人技术不是类人型的。它是完全自主的塔楼，在 30 分钟内提供 5G、ISR 和雷达，随处可用。</p>
<p>在下一轮合同之前获取投资者简报</p>
<p>由 CiTech 赞助</p>

TATE

<p>Tate & Lyle (伦敦证券交易所代码：TATE) 的股东在过去五年中面临了 35% 的损失，期间股价下跌了 53%。公司的每股收益（EPS）年均下降 28%，这也是导致下滑的原因之一。尽管市盈率为 47.44，暗示市场乐观，但总股东回报率（TSR）为-35%，表明分红在一定程度上缓解了损失。近期内部人士的买入是一个积极信号，但公司面临挑战，投资分析中指出了 4 个警示信号</p>

<p>Ideally, your overall portfolio should beat the market average. But every investor is virtually certain to have both over-performing and under-performing stocks. At this point some shareholders may be questioning their investment in <strong>Tate &amp; Lyle plc</strong> (LON:TATE), since the last five years saw the share price fall 53%. And some of the more recent buyers are probably worried, too, with the stock falling 48% in the last year. Shareholders have had an even rougher run lately, with the share price down 29% in the last 90 days.</p>
<div class="lb-trans"><p>理想情况下，您的整体投资组合应该超过市场平均水平。但几乎每位投资者都肯定会拥有表现优异和表现不佳的股票。在这一点上，一些股东可能在质疑他们对 <strong>Tate &amp; Lyle plc</strong> (LON:TATE) 的投资，因为过去五年股价下跌了 53%。而一些最近的买家可能也感到担忧，因为该股票在过去一年中下跌了 48%。股东们最近的表现更为糟糕，股价在过去 90 天内下跌了 29%。</p>
</div><p>Since shareholders are down over the longer term, lets look at the underlying fundamentals over the that time and see if they've been consistent with returns.</p>
<div class="lb-trans"><p>由于股东们在长期内处于亏损状态，让我们看看这段时间的基本面，看看它们是否与回报一致。</p>
</div><p>AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.</p>
<div class="lb-trans"><p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前布局。</p>
</div><p>While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price.</p>
<div class="lb-trans"><p>虽然市场是一个强大的定价机制，但股价反映的是投资者情绪，而不仅仅是基础业务表现。评估公司情绪变化的一个有缺陷但合理的方法是将每股收益（EPS）与股价进行比较。</p>
</div><p>During the five years over which the share price declined, Tate &amp; Lyle's earnings per share (EPS) dropped by 28% each year. This fall in the EPS is worse than the 14% compound annual share price fall. The relatively muted share price reaction might be because the market expects the business to turn around. With a P/E ratio of 47.44, it's fair to say the market sees a brighter future for the business.</p>
<div class="lb-trans"><p>在股价下跌的五年中，Tate &amp; Lyle 的每股收益（EPS）每年下降了 28%。每股收益的下降幅度超过了 14% 的年复合股价下跌幅度。相对温和的股价反应可能是因为市场预计业务会有所好转。以 47.44 的市盈率来看，可以说市场对该业务的未来持乐观态度。</p>
</div><p>The image below shows how EPS has tracked over time (if you click on the image you can see greater detail).</p>
<div class="lb-trans"><p>下图显示了每股收益随时间的变化（如果您点击图像，可以看到更详细的信息）。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/377904-earnings-per-share-growth-1-dark-2/1765614527926" alt="" original-src="https://images.simplywall.st/asset/chart/377904-earnings-per-share-growth-1-dark-2/1765614527926"/></p>
<p>LSE:TATE Earnings Per Share Growth December 13th 2025</p>
<div class="lb-trans"><p>LSE:TATE 每股收益增长 2025 年 12 月 13 日</p>
</div><p>It's probably worth noting we've seen significant insider buying in the last quarter, which we consider a positive. On the other hand, we think the revenue and earnings trends are much more meaningful measures of the business. Dive deeper into the earnings by checking this interactive graph of Tate &amp; Lyle's earnings, revenue and cash flow.</p>
<div class="lb-trans"><p>值得注意的是，我们在上个季度看到显著的内部人士买入，这被我们视为积极信号。另一方面，我们认为收入和收益趋势是衡量业务更有意义的指标。通过查看 Tate &amp; Lyle 的收益、收入和现金流的互动图表，可以更深入地了解收益情况。</p>
</div><h2>What About Dividends?</h2>
<div class="lb-trans"><h2>股息情况如何？</h2>
</div><p>When looking at investment returns, it is important to consider the difference between <em>total shareholder return</em> (TSR) and <em>share price return</em>. The TSR is a return calculation that accounts for the value of cash dividends (assuming that any dividend received was reinvested) and the calculated value of any discounted capital raisings and spin-offs. Arguably, the TSR gives a more comprehensive picture of the return generated by a stock. In the case of Tate &amp; Lyle, it has a TSR of -35% for the last 5 years. That exceeds its share price return that we previously mentioned. The dividends paid by the company have thusly boosted the <em>total</em> shareholder return.</p>
<div class="lb-trans"><p>在考虑投资回报时，重要的是要考虑 <em>总股东回报</em> (TSR) 和 <em>股价回报</em> 之间的差异。TSR 是一种回报计算，考虑了现金股息的价值（假设收到的任何股息都被再投资）以及任何折扣资本筹集和分拆的计算价值。可以说，TSR 提供了股票产生的回报的更全面的图景。在 Tate &amp; Lyle 的情况下，过去 5 年的 TSR 为-35%。这超过了我们之前提到的股价回报。因此，公司支付的股息提升了 <em>总</em> 股东回报。</p>
</div><h2>A Different Perspective</h2>
<div class="lb-trans"><h2>不同的视角</h2>
</div><p>Tate &amp; Lyle shareholders are down 46% for the year (even including dividends), but the market itself is up 20%. Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. Unfortunately, last year's performance may indicate unresolved challenges, given that it was worse than the annualised loss of 6% over the last half decade. We realise that Baron Rothschild has said investors should &#34;buy when there is blood on the streets&#34;, but we caution that investors should first be sure they are buying a high quality business. It's always interesting to track share price performance over the longer term. But to understand Tate &amp; Lyle better, we need to consider many other factors. Even so, be aware that Tate &amp; Lyle is showing <strong>4 warning signs in our investment analysis</strong> , and 2 of those are concerning...</p>
<div class="lb-trans"><p>Tate &amp; Lyle 的股东今年下跌了 46%（即使包括股息），但市场本身上涨了 20%。即使是优质股票的股价有时也会下跌，但我们希望在对业务产生浓厚兴趣之前，看到基本指标的改善。不幸的是，去年的表现可能表明存在未解决的挑战，因为其表现比过去五年年化损失 6% 还要糟糕。我们意识到巴伦·罗斯柴尔德曾说过，投资者应该在 “街头有血时” 买入，但我们提醒投资者首先要确保他们购买的是高质量的企业。长期跟踪股价表现总是很有趣。但要更好地理解 Tate &amp; Lyle，我们需要考虑许多其他因素。即便如此，请注意，Tate &amp; Lyle 在我们的投资分析中显示出 <strong>4 个警告信号</strong>，其中 2 个令人担忧……</p>
</div><p>Tate &amp; Lyle is not the only stock insiders are buying. So take a peek at this <strong>free</strong> list of small cap companies at attractive valuations which insiders have been buying.</p>
<div class="lb-trans"><p>Tate &amp; Lyle 并不是唯一一个内部人士在买入的股票。所以请查看这份 <strong>免费</strong> 的吸引人估值的小型公司名单，内部人士正在买入。</p>
</div><p><em>Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on British exchanges.</em></p>
<div class="lb-trans"><p><em>请注意，本文中引用的市场回报反映了目前在英国交易所交易的股票的市场加权平均回报。</em></p>
</div><p>Mobile Infrastructure for Defense and Disaster</p>
<div class="lb-trans"><p>移动基础设施用于国防和灾害</p>
</div><p>The next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.</p>
<div class="lb-trans"><p>下一波机器人技术不是类人型的。它是完全自主的塔楼，在 30 分钟内提供 5G、ISR 和雷达，随处可用。</p>
</div><p>Get the investor briefing before the next round of contracts</p>
<div class="lb-trans"><p>在下一轮合同之前获取投资者简报</p>
</div><p>Sponsored On Behalf of CiTech</p>
<div class="lb-trans"><p>由 CiTech 赞助</p>
</div>

Tate & Lyle (LON:TATE) 的股东在五年前投资该股票后，已经遭受了 35% 的损失